Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F19%3AN0000031" target="_blank" >RIV/00064173:_____/19:N0000031 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/19:10395608 RIV/00064203:_____/19:10395608
Result on the web
<a href="https://doi.org/10.21873/invivo.11571" target="_blank" >https://doi.org/10.21873/invivo.11571</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.21873/invivo.11571" target="_blank" >10.21873/invivo.11571</a>

Result language
angličtina
Original language name
Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer
Original language description
Circulating tumor cells (CTCs), detached from the primary tumor or metastases and shed in the patient's bloodstream, represent a relatively easily obtainable sample of the cancer tissue that can indicate the actual state of cancer, and their evaluation can be repeated many times during the course of treatment. As part of liquid biopsy, evaluation of CTCs provides a lot of clinically relevant information, which reflects the actual, real-time conditions of the disease. CTCs can be used in cancer diagnosis or screening, real-time long-term disease monitoring and even therapy guidance. Their analysis can include their number, morphology, and biological features by using immunocytochemistry and all "-omic" technologies. This review describes methods of CTC isolation and potential clinical utilization in lung cancer.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)